Noble launches its YpsoMate training device platform, elevates patient access
Noble unveiled today a new injectiontraining platform based on 1 mL and 2.25 mL YpsoMate devices to helpimprove patient onboarding and health outcomes.
Pharmaceuticals, Biotechnology and Life Sciences
Noble unveiled today a new injectiontraining platform based on 1 mL and 2.25 mL YpsoMate devices to helpimprove patient onboarding and health outcomes.
Mission Therapeutics today announced the appointment of Dr. James Summers asan independent member to its Board of Directors, with immediate effect.
Chinese registrational clinical trial for derazantinib to begin in 2H 2019 BURLINGTON, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ARQL&src=ctag” target=”_blank”gt;$ARQLlt;/agt; lt;a href=”https://twitter.com/hashtag/arql?src=hash” target=”_blank”gt;#arqllt;/agt;–ArQule, Inc.’s…
– First-quarter 2019 product revenues of $857 million, a 34% increase compared to $638 million in 2018- – First-quarter 2019…
− In the United States, Company Completes Tenth Value-Based Agreement with Commercial Payers, and Achieves Confirmed Access to ONPATTRO for…
DUBLIN–(BUSINESS WIRE)–The “Cell Expansion Market by Product, Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer &…
DUBLIN–(BUSINESS WIRE)–The “Working Through Veterinary Drug Development in the EU and USA” conference has been added to ResearchAndMarkets.com’s offering. This…
DUBLIN–(BUSINESS WIRE)–The “Development of Combination Products: Critical Interactions” conference has been added to ResearchAndMarkets.com’s offering. Linking the technical requirements of…
-Opportunity to treat the underlying cause of CF earlier than ever before- -Safety data from Phase 3 ARRIVAL study support…
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia–(BUSINESS WIRE)–Date of conference call should read:…